Latest news
InnoCan Pharma's Defining Moment: A Shareholder Vote That Could Settle the US Listing Question - AD HOC NEWSAD HOC NEWS · Sun, 09 Aug 2026 04:23:41 GMTInnoCan Pharma's August Crossroads: A Rebrand Vote, a Consumer Milestone, and the Cost of Waiting - AD HOC NEWSAD HOC NEWS · Sat, 08 Aug 2026 14:55:07 GMTInnoCan Pharma's Balancing Act: US Listing Hopes, Geopolitical Headwinds, and a Wellness Engine - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 03:40:55 GMTInnoCan Pharma's Waiting Game: SEC Review Drags On as Consumer Arm Hits New Milestones - AD HOC NEWSAD HOC NEWS · Thu, 06 Aug 2026 00:31:07 GMTInnoCan Pharma Corporation (CN:INNO) Extends Losses as Weak Sentiment and Market Uncertainty Pressure Shares - kalkine.cakalkine.ca · Wed, 05 Aug 2026 09:31:00 GMTInnoCan Pharma's Wellness Engine Hits 2 Million Customers as Shareholders Prepare for a Defining Vot - AD HOC NEWSAD HOC NEWS · Wed, 05 Aug 2026 04:41:36 GMTInnoCan Pharma's Identity Shift: What the Velsa Vote Really Means for Investors - AD HOC NEWSAD HOC NEWS · Mon, 03 Aug 2026 16:32:35 GMTInnoCan Pharma Corporation Revenue Breakdown – CSE:INNO - TradingViewTradingView · Thu, 30 Jul 2026 10:35:45 GMT